Stiff gels are important for coaxing adult stem cells to differentiate into muscle cells. Making muscle cells from adult stem cells in the lab would provide important new sources of high quality cells for a wide range of cell-based regenerative therapies to treat a diverse set of muscle diseases, from muscular dystrophy to heart attacks.
This week,
Engler received a $1.5 million grant from the US National Institutes of Health (NIH) to develop these stem cell niches over the next five years.
The images above highlight the
progress Engler has already made. Both images above are
adult mesenchymal stem cells (or
MSCs). The adult stem cells on the left were grown on gels with stiffness of 1
kPa (i.e. soft). The same type of stem cells (right) were grown on intermediately stiff gels (11
kPa). The 11
kPa gel recapitulates muscle stiffness, hence the adult
mesenchymal stem cells on the right expressed
MyoD, the protein labeled in the green color.
MyoD plays a key role in regulating muscle differentiation. The 1
kPa gel (left) is too soft, so those cells do not make the
MyoD protein and most but not all lack green staining. The new project, funded by Adam
Engler’s five-year $1.5 million NIH Director’s New Innovator Award, will integrate the cue of matrix stiffness with matrix topography and growth factors in a time and spatially-dependent way in order to make a more complete stem cell niche.
Learn about all the NIH New Innovator Award Recipients for 2009 here.
Scott LaFee mentioned Adam Engler in a
San Diego Union Tribune story about other recent NIH grants to UC San Diego and the La Jolla Institute for Allergy & Immunology.